AI Turned to Cancer Detection in Liquid Biopsy
September 25, 2018 | Terry Sharrer
With tumor biopsies, pathologists have a significant amount of tissue to examine, and with DNA sequencing they can determine what mutations and how many of them are present. Cell-free DNA fragments in blood, however, are harder to find and analyze, which is why artificial intelligence applied to identifying mutation “patterns” from multiple fragments across a genome could offer earlier cancer detection and better treatment monitoring. As this piece reports, one algorithm detected non-small cell lung cancer with 90% sensitivity in two patients, which was an improvement over standard liquid biopsy methods. MORE
Image Credit: Wikimedia.commons